Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>UBS Elevates HKEX (00388.HK) TP to $430, Keeps Rating at Neutral
Recommend 16 Positive 23 Negative 6 |
||||
|
||||
|
UBS published a research report expecting HKEX (00388.HK)'s 2Q25 NPAT/ revenue to increase 35%/ 30% to $4.3 billion/ $7 billion each, 11%/ 7% higher than market consensus, mainly due to better-than-expected net investment income (NII). The broker anticipated full-year NPAT/ revenue to rise by 16% YoY to $15 billion/ $30 billion. UBS also raised its 2025/ 2026/ 2027 ADT forecasts by 14%/ 9%/ 8% to $218 billion/ $185 billion/ $208 billion, and EPS forecasts by 5%/ 2%/ 4% to $11.9/ $10.5/ $11.5, respectively. Therefore, the broker elevated its target price from $393 to $430, with rating kept at Neutral. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
